000 01386 a2200397 4500
005 20250518045414.0
264 0 _c20191213
008 201912s 0 0 eng d
022 _a1942-0994
024 7 _a10.1155/2019/7285434
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLiu, Kun
245 0 0 _aMangiferin Attenuates Myocardial Ischemia-Reperfusion Injury via MAPK/Nrf-2/HO-1/NF-
_h[electronic resource]
260 _bOxidative medicine and cellular longevity
_c2019
300 _a7285434 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCardiotonic Agents
_xpharmacology
650 0 4 _aGene Expression Regulation
_xdrug effects
650 0 4 _aHeme Oxygenase (Decyclizing)
_xgenetics
650 0 4 _aIn Vitro Techniques
650 0 4 _aMale
650 0 4 _aMitogen-Activated Protein Kinase 1
_xgenetics
650 0 4 _aMyocardial Reperfusion Injury
_xmetabolism
650 0 4 _aNF-E2-Related Factor 2
_xgenetics
650 0 4 _aNF-kappa B
_xgenetics
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aXanthones
_xpharmacology
700 1 _aWang, Fei
700 1 _aWang, Shuo
700 1 _aLi, Wei-Nan
700 1 _aYe, Qing
773 0 _tOxidative medicine and cellular longevity
_gvol. 2019
_gp. 7285434
856 4 0 _uhttps://doi.org/10.1155/2019/7285434
_zAvailable from publisher's website
999 _c29846194
_d29846194